EP3209330
AN INHALABLE SIROLIMUS FORMULATION FOR THE TREATMENT OF PULMONARY HYPERTENSION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
7.10.2015EP published:
23.2.2022EP application number:
15787076.7
EPO information:
European Patent Register
Max expiry date:
6.10.2035
Title in English:
AN INHALABLE SIROLIMUS FORMULATION FOR THE TREATMENT OF PULMONARY HYPERTENSIONLanguage of the patent:
English
Timeline
Today
7.10.2015EP application
23.2.2022EP Publication
Owner
Name:
AI Therapeutics, Inc.Address:
530 Old Whitfield Street, Guilford, CT 06437, US
Inventor
Name:
ARMER, ThomasAddress:
Guilford, CT 06437, US
Name:
MELVIN, Lawrence S. Jr.Address:
Guilford, CT 06437, US
Name:
ROTHBERG, Jonathan M.Address:
Guilford, CT 06437, US
Name:
LICHENSTEIN, HenriAddress:
Guilford, CT 06437, US
Priority
Number:
201462060988 PDate:
7.10.2014Country:
US
Number:
201562144145 PDate:
7.4.2015Country:
US
Classification
Categories:
A61K 31/436, A61K 9/12, A61K 45/06, A61K 9/00, A61K 31/557, A61P 11/00